OXILAN ioxilan injection solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Nopērc to tagad

Produkta apraksts Produkta apraksts (SPC)
28-10-2017

Aktīvā sastāvdaļa:

ioxilan (UNII: A4YJ7J11TG) (ioxilan - UNII:A4YJ7J11TG)

Pieejams no:

Guerbet LLC

SNN (starptautisko nepatentēto nosaukumu):

ioxilan

Kompozīcija:

ioxilan 300 mg in 1 mL

Receptes veids:

PRESCRIPTION DRUG

Autorizācija statuss:

New Drug Application

Produkta apraksts

                                OXILAN- IOXILAN INJECTION INJECTION, SOLUTION
GUERBET LLC
----------
OXILAN (IOXILAN INJECTION) 300 MGI/ML
OXILAN (IOXILAN INJECTION) 350 MGI/ML
OXILAN (IOXILAN INJECTION) 300 MGI/ML PHARMACY BULK PACKAGE
OXILAN (IOXILAN INJECTION) 350 MGI/ML PHARMACY BULK PACKAGE
NONIONIC CONTRAST AGENTS
NOT FOR INTRATHECAL USE
PHARMACY BULK PACKAGE IS NOT FOR DIRECT INFUSION
DESCRIPTION
OXILAN® (Ioxilan Injection) formulations are stable, aqueous,
sterile, and non- pyrogenic solutions
for intravascular administration as diagnostic radiopaque media.
Ioxilan is designated chemically as N-
(2,3-dihydroxypropyl)-N’-(2-
hydroxyethyl)-5-[N-(2,3-dihydroxypropyl) acetamido]-2,4,6-
triiodoisophthal-amide and has the following structural formula:
The molecular weight of ioxilan is 791.12 and the organically bound
iodine content is 48.1%. Ioxilan is
nonionic and does not dissociate in solution. OXILAN® (Ioxilan
Injection) Pharmacy Bulk Package is
available in two strengths: OXILAN® (Ioxilan Injection) 300 mgI/mL
and OXILAN® (Ioxilan Injection)
350 mgI/mL.
Each mL of OXILAN® (Ioxilan Injection) 300 mgI/mL provides 623 mg
ioxilan. Each mL of
OXILAN® (Ioxilan Injection) 350 mgI/mL provides 727 mg ioxilan. Each
mL of OXILAN® (Ioxilan
Injection) 300 mgI/mL Pharmacy Bulk Package provides 623 mg ioxilan.
Each mL of OXILAN® (Ioxilan Injection) 350 mgI/mL Pharmacy Bulk
Package provides 727 mg
ioxilan.
Each mL of OXILAN® solution contains 0.1 mg edetate calcium disodium
(anhydrous basis), 1.0 mg
tromethamine, 0.5 mg sodium chloride and a minimum of 0.2 mg (0.01
mEq) sodium. The pH is adjusted
to 6.8 (5.5 to 7.5) with hydrochloric acid and sodium hydroxide. The
solutions contain no preservative.
Pertinent physicochemical data are below. OXILAN® (Ioxilan Injection)
is hypertonic compared to
plasma (approximately 285 mOsm/kg water).
®
®
®
®
Concentration (mgI/mL)
Concentration W/V
300
350
Measured Osmolality
(mOsm/kg water)
@ 37°C
610
721
Viscosity (cPs)
@ 37°C
@ 20°C
5.1
9.4
8.1
16.3
Specific Gravity
@ 37°C
@ 20°C
1.319
1.327
1.3
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu